Long-term effectiveness and safety of natalizumab in a Portuguese population.
Correia I, Batista S, Galego O, Marques IB, Jesus-Ribeiro J, Martins AI, Nunes C, Macário MC, Cunha L, Sousa L.
Correia I, et al. Among authors: batista s.
Int Immunopharmacol. 2017 May;46:105-111. doi: 10.1016/j.intimp.2017.03.006. Epub 2017 Mar 7.
Int Immunopharmacol. 2017.
PMID: 28282574